Details of Disease | DrugMAP

General Information of Disease (ID: DISVDFS2)

Disease Name	Geographic retinal atrophy
Disease Class	9B71: Retinopathy
Disease Hierarchy	DIS01GPL: Grass pollen hypersensitivity DISVDFS2: Geographic retinal atrophy
ICD Code	ICD-11 ICD-11: 9B78.9

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)

This Disease is Treated as An Indication in 3 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Lampalizumab	DMA2NYS	Phase 3	Antibody	[1]
CLG561	DMU6R3O	Phase 2	Antibody	[2]
HMR59	DMMQZ3I	Phase 2	Gene therapy	[3]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1	ClinicalTrials.gov (NCT02745119) Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT). U.S. National Institutes of Health.
2	ClinicalTrials.gov (NCT02515942) CLG561 Proof-of-Concept Study as a Monotherapy and in Combination With LFG316 in Subjects With Geographic Atrophy (GA). U.S. National Institutes of Health.
3	ClinicalTrials.gov (NCT04358471) Intravitreal AAVCAGsCD59 for Advanced Dry Age-related Macular Degeneration (AMD) With Geographic Atrophy (GA). U.S. National Institutes of Health.